Bausch + Lomb Corporation (BLCO) Covered Calls

Bausch + Lomb Corporation is a leading global eye health company that offers a comprehensive portfolio of products, including contact lenses, lens care solutions, ophthalmic pharmaceuticals, and surgical devices. Spun off from Bausch Health in 2022, the company serves patients and healthcare professionals in approximately 100 countries, focusing on protecting and enhancing the gift of sight.

You can sell covered calls on Bausch + Lomb Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BLCO (prices last updated Tue 4:16 PM ET):

Bausch + Lomb Corporation (BLCO) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
18.44	+0.45	17.30	19.00	507K	-	6.4

Covered Calls For Bausch + Lomb Corporation (BLCO)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Mar 20	18	0.75	18.25	-1.4%	-20.4%
Apr 17	18	1.25	17.75	1.4%	9.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Core Business and Products

Bausch + Lomb is a world-renowned brand in vision care and ophthalmology. The company operates in three main segments: Vision Care (contact lenses and consumer eye health), Pharmaceuticals (prescription medicines for glaucoma and dry eye), and Surgical (intraocular lenses and equipment). Its well-known consumer brands include Biotrue, Lumify, and PreserVision. The company’s integrated approach allows it to provide life-cycle solutions for eye health, from daily disposable lenses to advanced surgical platforms used in cataract and vitreoretinal procedures.

Competitive Landscape

The global eye health market is characterized by high barriers to entry and intense competition among specialized medical device and pharmaceutical firms. BLCO competes directly with several large, publicly traded companies. Key rivals with active options markets on major exchanges include Alcon Inc. and Johnson & Johnson, both of which have significant market share in vision care and surgical equipment. In the pharmaceutical and contact lens segments, it also faces competition from The Cooper Companies, Inc. and AbbVie Inc.. Despite its spin-off, its former parent Bausch Health Companies Inc. remains a significant stakeholder and strategic point of comparison.

Strategic Outlook and Innovation

The company’s strategic focus is on accelerating revenue growth through new product launches and expanding its presence in the fast-growing dry eye disease market. Innovation efforts are centered on its "Vision 27" program, which aims to improve operational efficiency and margin expansion. Key growth drivers include the continued uptake of Miebo and Xiidra in the prescription dry eye space and the development of next-generation silicone hydrogel contact lenses. The long-term outlook for BLCO depends on its ability to navigate a complex regulatory landscape while successfully competing against newer, tech-focused entrants in the digital health and eye care diagnostic sectors.

Top 10 Open Interest For Mar 20 Expiration				Top 5 High Yield
1.	SLV covered calls	6.	EWZ covered calls	1.	LCID covered calls
2.	NVDA covered calls	7.	QQQ covered calls	2.	EOSE covered calls
3.	EEM covered calls	8.	GLD covered calls	3.	CRWV covered calls
4.	IBIT covered calls	9.	FXI covered calls	4.	WULF covered calls
5.	SPY covered calls	10.	KWEB covered calls	5.	ENVX covered calls

Want more examples? BLCN Covered Calls | BLD Covered Calls